Tellus Therapeutics

BiotechDurhamSeries A

www.tellustherapeutics.com

Develops treatments for newborns in the neonatal intensive care unit. Its lead candidate, TT-20, targets white matter brain injury in preterm infants and grew out of Duke research on compounds in breast milk that restore myelination.

At a glance

Founded: 2018
HQ: Durham
Sector: Biotech
Stage: Series A
Last round: Series A
Affiliation: Duke

No roles listed at Tellus Therapeutics right now.

If you want to work here anyway, tell us what you are after and Adam will pass it to the Tellus Therapeutics team when there is a real fit.

Listed roles

All Triangle roles

Checking listed roles…

The rest of this record is behind a free account.

Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately.